New copper IUD shows promise in early trial
NCT ID NCT02446821
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 study tested VeraCept, a copper intrauterine device (IUD), for long-acting contraception in 286 women aged 18-40. Researchers measured how well it prevents pregnancy and how easy it is to place. The results will help design a larger Phase 3 study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VeraCept copper intrauterine device (IUD)
What this could lead to
If successful, this could provide a new long-acting, hormone-free contraceptive option for women.
What could go wrong
This is an early Phase 2 study with only 286 participants, so results may not apply to everyone. IUDs carry risks like cramping, bleeding, or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Associates
Corpus Christi, Texas, United States
-
Clinical Research of Philadelphia
Philadelphia, Pennsylvania, United States
-
Columbia University Medical Center
New York, New York, United States
-
Essential Access Health (formerly California Family Health Council)
Burbank, California, United States
-
Essential Access Health (formerly California Family Health Council)
Los Angeles, California, United States
-
Healthcare Clinical Data, Inc
Miami, Florida, United States
-
Oregon Health and Sciences University
Portland, Oregon, United States
-
University of California Davis Health System
Sacramento, California, United States
-
University of Cincinnati
Cincinnati, Ohio, United States
-
University of Colorado
Aurora, Colorado, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, United States
-
University of Utah
Salt Lake City, Utah, United States